Frontlight ResearchEarly access
CompletedNo phase
A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life
Key facts
- Who runs it
- Takeda
- Where
- Canada, Germany, Spain, Sweden, Switzerland, and United Kingdom14 sites in 6 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 224 people enrolled
- Started
- 6 Nov 2023
- Ended
- 28 Jul 2025
- Type of study
- Observational, 2 groups
- Record updated
- 14 October 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Part I:
- Adult greater than or equal to (>=)18 years of age or Canadian adult >=19 years of age
- Ability to consent, as judged by the study investigator
- Diagnosis of at least one psychiatric disorder of at least 12 months duration, based on International classification of diseases (ICD)-10 codes registered in electronic health records
- Consecutive assessment for ADHD (as per routine clinical practice)
- Able to read and write in the first language of the respective country; Part II
- Inclusion in study Part I
- Diagnosis of ADHD during Part I, according to routine diagnostic procedure and algorithms
- Anticipated availability for being followed over 9 months
Who cannot take part
- Diagnosis of any of the following at any time prior to signing informed consent: schizoaffective disorder, intellectual disability, or other cognitive disorders
- Occurrence of any of the following events within the 6 months prior to signing consent: psychotic episodes, acute intoxication, or psychotropic drug withdrawal syndrome
- Participation in a clinical interventional trial in the 12 months prior signing consent; Part II:
- Serious and unstable medical condition (severe disease that limits survival to 1 year)
- Part I:
- Diagnosis of ADHD at any time before study inclusion
- Participant being followed-up for ADHD in a different site
This trial has no sites in United States.
It has sites in 6 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
The main aim of the study is to find out how frequently adults with at least one psychiatric condition have ADHD (but have not been diagnosed with ADHD before) and to describe the quality of life of these adults who have been diagnosed with ADHD. To find out how often ADHD is not diagnosed in these adults could provide awareness about this condition and could help to improve preventing underdiagnosis.
The 2 groups in the trial
- Part I: Participants with ADHD
Participants with psychiatric disorders undergoing ADHD diagnosis.
- Part II: Participants with ADHD
To collect pseudonymized data from participants who are underdiagnosed of ADHD with psychiatric disorders in daily clinical practice for up to 9 months from both Part I and II.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Prevalence of ADHD and Health Outcomes in Adult Outpatients With Psychiatric Disorders: a Multi-country, Two-part, Observational Study
- Record updated
- 14 October 2025